Premium
Methylprednisolone added to tocilizumab reduces mortality in SARS‐CoV‐2 pneumonia: An observational study
Author(s) -
Sanz Herrero F.,
Puchades Gimeno F.,
Ortega García P.,
Ferrer Gómez C.,
Ocete Mochón M. D.,
García Deltoro M.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13145
Subject(s) - tocilizumab , medicine , methylprednisolone , pneumonia , clinical trial , randomized controlled trial , regimen , intensive care unit , intensive care medicine , rheumatoid arthritis